|
Market Closed -
London S.E.
11:35:03 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 0.1300 GBX | -3.70% |
|
-10.34% | -61.19% |
| 09-15 | EARNINGS AND TRADING: Amcomri revenue up; Unicorn Namibia acquisition | AN |
| 09-15 | ValiRx plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VALIRX PLC | Bio Therapeutic Drugs | -3.70% | -10.34% | -61.19% | -79.20% | -99.51% | 2.38M |  | | |
- Stock Market
- Stocks
- VAL Stock
- Charts ValiRx plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
